Comparison between ELISA and ICT-MycoDot in childhood tuberculosis

Area of Science:

• Pediatric Infectious Diseases
• Immunodiagnostics
• Tuberculosis Research

Background:

• Childhood tuberculosis (TB) diagnosis presents significant challenges.
• Accurate and accessible diagnostic tools are crucial for effective management.
• Current diagnostic methods for pediatric TB require improvement.

Purpose of the Study:

• To evaluate the diagnostic performance of serum anti-TB IgG antibody detection using Enzyme Linked Immunosorbent Assay (ELISA) and Immunochromatography test (ICT) in childhood TB.
• To assess the utility of commercially available diagnostic kits (Pathozyme TB complex and MycoDot test) for pediatric TB.
• To compare the sensitivity and specificity of ELISA and ICT in confirmed and clinically diagnosed childhood TB cases.

Main Methods:

• A case-control study involving 52 children (4-14 years) with TB and 36 age/sex-matched controls.
• Serum samples were tested using ELISA (Pathozyme TB complex) and ICT (MycoDot test).
• Participants included AFB-positive confirmed TB, AFB-negative clinically diagnosed TB (pre- and on-treatment), healthy children, and children with non-specific pulmonary infections.

Main Results:

• ELISA demonstrated an overall sensitivity of 34.62% and specificity of 97.20%.
• MycoDot test showed an overall sensitivity of 48.08% and specificity of 96.92%.
• Both tests yielded higher positive rates in clinically diagnosed cases on treatment (ELISA: 71.42%, ICT: 85.71%) compared to AFB-positive confirmed cases (ELISA: 40%, ICT: 72.72%).

Conclusions:

• Neither ELISA nor ICT, using the evaluated commercial kits, can be considered a confirmatory test for childhood tuberculosis.
• The low sensitivity of these antibody detection methods in confirmed TB cases limits their diagnostic value.
• Further research into more sensitive and specific diagnostic markers for pediatric TB is warranted.